Login

Lindsay Partridge Reflects on 25 Years as Brickworks CEO Ahead of Retirement | Lindsay Partridge - CEO of brickworks ltd 00:10:00

Share On Facebook Share On Twitter

Lindsay Partridge is the CEO of brickworks ltd

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Antony Beckmand Highlights Kuniko's Carbon-Neutral Certification and Future Green Mining Goals | Antony Beckmand , CEO, Kuniko Limited.
00:10:00
Millicom CEO Mauricio Ramos credits Tigo employees for fostering a workplace committed to diversity, equity, and inclusion.
00:10:00
Expert Investment Advice from Kailash Kulkarni: Navigating Market Volatility and Long-Term Growth | Mr. Kailash Kulkarni, CEO , L&T Mutual Fund .
00:10:00
Adrian invests in eCom infrastructure, fintech, and healthtech|Adrian,CEO, Verbatim
00:00:00
Mike Timoney: Introduction to Smiles Inclusive - a new model for dental partnerships - Mike Timiney, CEO, Smiles Inclusive Ltd
00:10:00
German Junior Mining Company Expands Lithium Ventures in Argentina
00:10:00
How the Pemba Program Enhanced My Business Acumen in Healthcare
00:10:00
Executive interview - Bigblu Broadband | Andrew Walwyn, CEO, Bigblu Broadband PLCBBB:LSE
00:00:00
Dr. Bennie Jeng, Cornea expert, Chair of the Department of Ophthalmology
00:10:00
Grace Kwok on Advancing Net Zero | Grace Kwok, Chairman, Allied Sustainability & Environmental Consultants Group Ltd.
00:10:00
Unlocking Peru's Copper Potential: Joanne Freeze Discusses Candente Copper's Kanyaka Project and Market Dynamics
00:10:00
Professor David E. Bernstein on the Boundaries of Anti-Discrimination Laws|David E. Bernstein, Professor, George Mason University

© 2017 - Neuhu+